Valeurs

Valeurs

Le rangement donne un aperçu de toutes les valeurs mobilières classées de manière alphabétique ou selon les indices.

Show advanced options

A B C D E F G H I J K L M N O P Q R S T U V W X Y Z

Nom	Code	Analysis date	Cours de clôture	+/- %
BeiGene Ltd	49B	16. mai 2024	11.80	+2.61
Biofrontera AG	B8FK	16. mai 2024	3.90	-4.87
Biomed-Lubin Wytwornia Surowic I Szczepionek S.A.	6NQ	16. mai 2024	1.09	-2.84
Biophytis	6XB	16. mai 2024	0.00	0.00
Biotest AG	BIO3	16. mai 2024	27.80	+1.46
Bioton S.A.	7U5	16. mai 2024	0.84	+2.44
Bioventix Plc	51B	16. mai 2024	50.50	+1.00
Bone Therapeutics S.A.	BT1	16. mai 2024	0.01	+4.62
Cellectis	ZVA	16. mai 2024	2.74	+0.37
Celon Pharma SA	8RP	16. mai 2024	3.75	+0.13
Chromadex Corp	OCD1	16. mai 2024	3.30	-1.20
Circassia Group Plc	82C	16. mai 2024	0.82	-0.60
CKLIFE SCIENCES	LSI	16. mai 2024	0.05	+1.05
Clinuvel Pharmaceuticals Ltd	UR9A	16. mai 2024	9.60	+6.67
Clinuvel Pharmaceuticals Ltd Ordinary Shares (Australia)	UR9	16. mai 2024	9.21	-0.43
Csl Ltd SPONSORED ADR (Australia)	CSJA	16. mai 2024	87.00	+1.16
CSL Ltd.	CSJ	16. mai 2024	174.62	+1.09
CSTONE PHARMAC. DL-,0001	PH4	16. mai 2024	0.14	+9.92
CYNATA THERAPEUTICS LTD Ordinary Shares(Australia)	51S	16. mai 2024	0.14	+5.26
D.Western Therapeutics Institute, Inc.	6DW	16. mai 2024	0.56	+1.83
Diaceutics Plc	7DC	16. mai 2024	1.24	+5.98
E-Therapeutics Plc	3AQ	16. mai 2024	0.09	0.00
Everest Medicines Limited	6HN	16. mai 2024	2.76	0.00
Evgen Pharma Plc	8EV	16. mai 2024	0.00	0.00
Futura Medical	GYX	16. mai 2024	0.45	+0.45
Galapagos NV - American Depositary Shares	GXEA	16. mai 2024	25.60	+1.59
GeNeuro SA	GEM	16. mai 2024	1.49	+6.81
Genoway	JEH	16. mai 2024	4.04	-0.25
Genscript Biotech Corporation	G51	16. mai 2024	1.46	+1.39
GNI Group Ltd.	3G6	16. mai 2024	14.80	-0.67

Investtech guarantees neither the entirety nor accuracy of the analyses. Any consequent exposure related to the advice / signals which emerge in the analyses is completely and entirely at the investors own expense and risk. Investtech is not responsible for any loss, either directly or indirectly, which arises as a result of the use of Investtechs analyses. Details of any arising conflicts of interest will always appear in the investment recommendations. Further information about Investtechs analyses can be found here disclaimer. The content provided by Investtech.com is NOT SEC or FSA regulated and is therefore not intended for US or UK consumers.